You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
耀才团队: 疫苗快将面世 新旧经济股个别发展
阿思达克 11-10 11:06
耀才研究部称,隔晚(9日)美股表现波动,辉瑞(PFE.US)与BioNTech(BNTX.US)合作研发的新冠疫苗成效高达90%,市场憧憬疫苗快将面世,刺激道指开市後最多升1,610点,高见29,933点创历史新高,但宅经济股概念显着下挫,ZOOM(ZM.US)等今年热炒的宅经济相关股份跌幅逾一成以上,科技股回落拖累纳指倒跌1.5%。港股ADR造好,但局限於旧经济股,汇控(00005.HK)ADR大涨9.4%报38.13元,但腾讯(00700.HK)ADR则逆市下跌2%报609.05元。夜期收报26,516点,升482点或高水500点,料恒指今日(10日)将会裂口高开400点左近,但新经济股今日或面临回吐压力,恒生科技指数或可能逆市下跌。

从技术上看,昨日进一步裂口高开突破26,000点关口,目前较关键的阻力位上移至7月7日高位26,782点,料恒指短期之波幅区间将会在25,800点至26,800点。自美国总统大选後,环球市场气氛乐观,但恒指於11月的首六个交易日已累升近2,000点或约8%,并且遗留下多个上升裂口,故高位技术调整压力亦不容忽视。

(笔者为证监会持牌人)~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account